GLAUKOS Corp (GKOS) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, GLAUKOS reported revenue of $507.4M, up 32.3% from $383.5M the year before. Net income was -$187.7M (a -37.0% net margin), or -$3.28 per diluted share. Gross margin was 55.7% and operating margin was -39.3%. Operating activities generated -$14.8M of cash, leaving -$22.5M of free cash flow. At fiscal year end, GLAUKOS held $893.5M in total assets against $237.3M in total liabilities, including $90.8M of cash and equivalents.
Open the full interactive GLAUKOS financials → Quarterly statements, key ratios, valuation history and price charts.
GLAUKOS Key Stats
| Share Price | $165.50 |
|---|---|
| Market Cap | $9.73B |
| Revenue YoY Growth | +32.3% |
| 52-Week Range | $74.67 – $189.55 |
| Shares Outstanding | 58.8 million (basic, 2026 Q2) |
GLAUKOS Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $225.0M | $294.0M | $282.9M | $314.7M | $383.5M | $507.4M |
| Cost of Goods Sold | $91.7M | $66.6M | $69.0M | $75.6M | $94.0M | $111.8M |
| Gross Profit | $133.2M | $227.4M | $213.9M | $239.1M | $289.5M | $282.8M |
| Operating Income | -$123.6M | -$32.9M | -$82.3M | -$128.7M | -$122.4M | -$199.6M |
| Pre-Tax Income | -$132.3M | -$49.3M | -$98.4M | -$133.7M | -$145.6M | -$193.0M |
| Income Tax | -$12.0M | $326,000 | $766,000 | $934,000 | $771,000 | -$5.4M |
| Net Income | -$120.3M | -$49.6M | -$99.2M | -$134.7M | -$146.4M | -$187.7M |
| Diluted EPS | -$2.70 | -$1.07 | -$2.09 | -$2.78 | -$2.77 | -$3.28 |
GLAUKOS Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $133.5M | $143.1M | $150.6M | $185.6M |
| Net Income | -$16.2M | -$133.7M | -$19.8M | -$18.4M |
| Diluted EPS | -$0.28 | -$2.34 | -$0.34 | -$0.31 |
GLAUKOS Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $96.6M | $100.7M | $119.5M | $93.5M | $169.6M | $90.8M |
| Current Assets | $469.4M | $486.1M | $443.9M | $395.5M | $449.8M | $475.0M |
| Total Assets | $1.01B | $1.05B | $1.00B | $940.4M | $974.8M | $893.5M |
| Current Liabilities | $49.7M | $63.4M | $72.4M | $74.0M | $75.1M | $101.3M |
| Total Long-Term Debt | $189.4M | $280.0M | $281.4M | $282.8M | — | — |
| Total Liabilities | $338.1M | $462.5M | $472.4M | $478.6M | $207.8M | $237.3M |
| Shareholders' Equity | $667.4M | $587.2M | $530.0M | $461.8M | $766.9M | $656.2M |
GLAUKOS Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$23.0M | $24.7M | -$33.1M | -$57.8M | -$61.3M | -$14.8M |
| Cash From Investing | -$205.1M | -$58.2M | $44.8M | $14.1M | $47.8M | -$77.6M |
| Cash From Financing | $262.5M | $39.3M | $6.3M | $15.0M | $91.5M | $11.9M |
| Free Cash Flow | -$29.9M | -$23.1M | -$63.4M | -$78.0M | -$67.6M | -$22.5M |
Figures from GLAUKOS's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full GLAUKOS financials page for every line item.
GLAUKOS Company Profile
| Ticker | GKOS |
|---|---|
| Exchange | NYSE |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Aliso Viejo, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001192448 |
Frequently Asked Questions
What was GLAUKOS's revenue in fiscal 2025?
GLAUKOS (GKOS) reported revenue of $507.4M for fiscal 2025.
What is GLAUKOS's annual revenue history?
GLAUKOS's annual revenue by fiscal year: 2020: $225.0M; 2021: $294.0M; 2022: $282.9M; 2023: $314.7M; 2024: $383.5M; 2025: $507.4M.
What was GLAUKOS's net income in fiscal 2025?
GLAUKOS reported net income of -$187.7M for fiscal 2025.
What was GLAUKOS's earnings per share (EPS) in fiscal 2025?
GLAUKOS's diluted EPS was -$3.28 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did GLAUKOS generate in fiscal 2025?
GLAUKOS generated -$22.5M of free cash flow in fiscal 2025.
What was GLAUKOS's revenue last quarter?
In its most recent reported quarter (2026 Q2), GLAUKOS reported revenue of $185.6M.
How many shares of GLAUKOS are outstanding?
GLAUKOS reported a weighted average of 58.8 million basic shares outstanding in 2026 Q2.
What is GLAUKOS's market cap?
Based on its latest closing price, GLAUKOS (GKOS) has a market capitalization of about $9.73B.
When does GLAUKOS's fiscal year end?
GLAUKOS's fiscal year end, as registered with the SEC, is December 31.
Where is GLAUKOS headquartered?
GLAUKOS lists its business address in Aliso Viejo, California in its SEC filings.